# FDA Inspection 1254221 - Biomat USA, Inc. - November 06, 2024

Source: https://www.globalkeysolutions.net/records/fda_inspections/biomat-usa-inc/2e75acfc-523e-45d6-8cf4-a9bdbed254f0
Source feed: FDA_Inspections

> FDA Inspection 1254221 for Biomat USA, Inc. on November 06, 2024. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1254221
- Company Name: Biomat USA, Inc.
- Inspection Date: 2024-11-06
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1254221 - 2024-11-06](https://www.globalkeysolutions.net/records/fda_inspections/biomat-usa-inc/db9359da-6352-4e3e-9dc3-7c5a3f36e8e7)
- [FDA Inspection 1058207 - 2018-06-27](https://www.globalkeysolutions.net/records/fda_inspections/biomat-usa-inc/c63f90aa-59bb-4db9-96fe-6814943c2fd4)
- [FDA Inspection 914200 - 2015-02-13](https://www.globalkeysolutions.net/records/fda_inspections/biomat-usa-inc/dba3bf84-69c0-4b12-82f7-91906a62bcd0)
- [FDA Inspection 792818 - 2012-08-01](https://www.globalkeysolutions.net/records/fda_inspections/biomat-usa-inc/0e4f6742-1b62-45db-9a48-fc2586ad5c39)
- [FDA Inspection 676918 - 2010-08-19](https://www.globalkeysolutions.net/records/fda_inspections/biomat-usa-inc/2edaf71d-1b32-4ebc-a0a8-b9be91e0c952)

Company: https://www.globalkeysolutions.net/companies/biomat-usa-inc/2f03ac60-272d-4fc7-a474-c99ba357440d

Office: https://www.globalkeysolutions.net/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d